Programme

Please click the sessions for the detailed programme.

Thursday, 24 SEPTEMBER

08.30-09.00 Opening Ceremony
09.00-11.00
State of the Art Lecture, Plenary Lecture Plenary Room
STA1 What’s new in pre-eclampsia? Mark Brown St. George Hospital & University of NSW, Department of Renal Medicine, Sydney, Australia STA2 Placentation and pre-eclampsia - inflammatory and immunological issues Christopher Redman University of Oxford, Nuffield Department of Obstetrics and Gynaecology, Oxford, UK STA3 Novel therapies for preeclamsia Ananth Karumanchi Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA PL136 Renal disease before, during and after preeclampsia Markus G. Mohaupt University Hospital Bern, Department of Nephrology, Hypertension and Clinical Pharmacology, Bern, Switzerland
11.00-11.30 Coffee Break
11.30-13.00
Oral communication – Genetic of preeclampsia Plenary Room
O4 Genome wide sequencing approaches to identify missing heritability of preeeclampsia Eric Mosessu1, Phillip Meltonsu1, Matthew Johnsonsu2, Dnyanada Gokhale-Agashesu1, Alex Reasu1, Richard Allcocksu3, John Blangerosu2, Shaun Brenneckesu4 1University of Western Australia, Centre for Genetic Origins of Health and Disease, Perth, Australia
2University of Texas Health Science Center at San Antonio, South Texas Diabetes and Obesity Institute, Brownsville, USA
3University of Western Australia, School Pathology and Laboratory Medicine, Perth, Australia
4Royal Women's Hospital / University of Melbourne, Pregnancy Research Centre, Department of Perinatal Medicine, Melbourne, Australia
O5 Next-generation sequencing studies in Finnish preeclampsia cohorts Tea Kaartokallio1, JIngwen Wang2, Hong Jiao2, Seppo Heinonen3, Eero Kajantie4, Juha Kere2, Katja Kivinen5, Anneli Pouta6, Hannele Laivuori1 1University of Helsinki and Helsinki University Hospital, Medical and Clinical Genetics, Helsinki, Finland
2Karolinska Institute, Department of Biosciences and Nutrition, Center for Innovative Medicine and Science for Life Laboratory, Stockholm, Sweden
3University of Helsinki and Helsinki University Hospital, Obstetrics and Gynecology, Helsinki, Finland
4National Institute for Health and Welfare, Department of Chronic Disease Prevention, Diabetes Prevention Unit, Helsinki, Finland
5University of Cambridge, Division of Cardiovascular Medicine, Cambridge, UK
6National Institute for Health and Welfare, Department of Children, Young People and Families, Oulu, Finland
O6 Association between fetal congenital heart defects and maternal risk of hypertensive disorders of pregnancy in concurrent and subsequent pregnancies Heather Boyd1, Saima Basit1, Ida Behrens1, Elisabeth Leirgul2, Henning Bundgaard3, Jan Wohlfahrt1, Mads Melbye1, Nina Øyen2 1Statens Serum Institut, Department of Epidemiology Research, Copenhagen, Denmark
2University of Bergen, Department of Global Public Health and Primary Care, Bergen, Norway
3Copenhagen University Hospital (Rigshospitalet), Heart Centre, Copenhagen, Denmark
O7 Epigenome of the circadian clock pathway of placental and newborn tissues in pre-eclampsia Caroline Van den Berg1, Ines Chaves2, Emilie Herzog1, Sten Willemsen3, Bert Van der Horst2, Régine Steegers-Theunissen1 1Erasmus MC, Department of Obstetrics & Gynecology, Rotterdam, The Netherlands
2Erasmus MC, Department of Genetics, Rotterdam, The Netherlands
3Erasmus MC, Department of Biostatistics, Rotterdam, The Netherlands
O8 Cardiovascular risk factors, renin-angiotensin system gene polymorphisms, pregnancy course and outcomes in women with different forms of hypertension Vasiliy Chulkov1, Natalya Vereina1, Sergei Sinitsin1, Valentina Dolgushina2 1South Ural State Medical University, Russia, Faculty Therapy Department, Chelyabinsk, Russia
2South Ural State Medical University, Russia, Department of Obstetrics and Gynecology, Chelyabinsk, Russia
O9 The functional role of natriuretic peptides in preeclampsia Gábor Szabó, Bálint Nagy, János Rigó Jr. Semmelweis University, 1st Department of Obstetrics and Gynaecology, Budapest, Hungary
Oral communication – Pathophisiology of preeclampsia Section Room
O11 Evaluation of the endocannabinoid system in preeclampsia Attila Molvarec1, Gergely Fügedi1, Miklós Molnár2, Eszter Szabó3, Júlia Schönléber1, János Rigó Jr1 1Semmelweis University, 1st Department of Obstetrics and Gynaecology, Budapest, Hungary
2Semmelweis University, Institute of Pathophysiology, Budapest, Hungary
3Semmelweis University, 1st Department of Pediatrics, Budapest, Hungary
O12 Analysis of the molecular and cellular mechanisms regulated by magnesium sulphate in an in vitro model of the human placenta Rachel Williamson1, Gerard O'Keeffe2, Louise Kenny1 1University College Cork, 1st Department of Obstetrics and Gynaecology, Cork, Ireland
2University College Cork, Department of Anatomy and Neuroscience, Cork, Ireland
O13 Catechol-O-methyltransferase deficiency leads to hypersensitivity on the pressor response against angiotensin II Norikazu Ueki1, Satoru Takeda1, Megumi Kanasaki2, Daisuke Koya2, Keizo Kanasaki2 1Juntendo University Faculty of Medicine, Department of Obstetrics and Gynecology, Tokyo, Japan
2Kanazawa Medical University, Department of Diabetology and Endocrinology, Ishikawa, Japan
O14 Is preeclampsia a variant of Liddles syndrome with enhanced activity of the epithelial sodium channel in the kidneys? Lise Hald Nielsen1, Per Ovesen1, Boye Jensen2 1Aarhus University, Department of Gynecology and Obstetrics, Aarhus, Denmark
2Odense University Hospital, Department of Cardiovascular and Renal Research, Odense, Denmark
O15 Adipose tissue and adipocytokine in preeclampsia: New insights into danger signals and inflammation Katsuhiko Naruse Nara Medical University, Department of Obstetrics & Gynecology, Kashihara, Japan O10 Increased Maternal and Fetal HDL Cholesterol Efflux Capacity and Placental CYP27A1 Expression in Pre-eclampsia Hiten Mistry1, Lesia Kurlak2, Yosef Mansour3, Line Zurkinden1, Markus Mohaupt4, Geneviève Escher1 1University of Bern, Department of Nephrology, Hypertension and Clinical Pharmacology, Berne, Switzerland
2University of Nottingham, Obstetrics and Gynecology, Nottingham, UK
3King's College London, Women's Health Academic Centre, London, UK
4University of Bern, Department of Nephrology, Hypertension and Clinical Pharmacology, Berne, UK
13.00-13.45 Lunch symposium (detailed programme available under the Sponsors menu)
13.45-14.15 Break
14.15-15.45
Oral communication – Markers of preeclampsia Plenary Room
O16 Marinobufagenin as a promising preeclampsia risk assessment marker: purification from toad venom and LC-MS identification in human plasma Charline Lenaerts1, Liz Bond2, Robin Tuytten2, Bertrand Blankert1 1University of Mons, Laboratory of Pharmaceutical Analysis, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, Mons, Belgium
2Metabolomic Diagnostics, Cork, Ireland
O18 Oxidative stress in preeclampsia Hajnalka Hejja1, Nora Fekete2, Balint Alasztics1, Jozsef Gabor Joo1, Attila Molvarec 1, Katalin Szabo-Taylor2, Edit Buzas2, Janos Rigo1, Eva Pallinger2 1Semmelweis University, 1st Department of Obstetrics and Gynaecology, Budapest, Hungary
2Semmelweis University, Department of Genetics, Cell- and Immunobiology, Budapest, Hungary
O19 Decreased plasma hemopexin activity in preeclampsia is associated with decreased plasma AT-1 receptor leves and increased placental and monocyte AT-1 receptor expression Floor Spaan1, Theo Borghuis1, Paul De Vos1, Harry Van Goor1, Maria Van Pampus2, Marijke Faas1 1University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands
2University Medical Center Groningen, Department of Obstetrics & Gynecology, Groningen, The Netherlands
O20 NT-pro-BNP levels as a marker of high clinical risk in pregnancy Marcela Cleila Cabo Fustaret, Ana Escobar, Fedor Novo, Ricardo Illia, Carlos Rivas, Matias Uranga Imaz, Guillermo Lobenstein, Roberto Mayer, Patricia Olejnik, Tomas Garcia Balcarce, Guido Manrique Hospital Alemán, Department of Cardiology /Obstetric and Gynecology , Buenos Aires, Argentina O21 First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with later pre-eclampsia Elina Keikkala1, Sini Koskinen1, Piia Vuorela1,2, Hannele Laivuori1,3,4, Jarkko Romppanen5, Seppo Heinonen1, Ulf-Håkan Stenman6 1Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
2Obstetrics and Gynecology, Porvoo Hospital, Porvoo, Finland
3Medical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
4Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland
5Eastern Finland Laboratory Centre, Kuopio, Finland
6Clinical Chemistry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Oral communication - Prediction of preeclampsia Section Room
O22 Correlation of sFlt-1/PlGF ratio with time to delivery or preterm birth in PROGNOSIS (Prediction of short-term outcome in pregnant women with suspected preeclampsia study) Harald Zeisler1, Elisa Llurba2, Frederic Chantraine3, Manu Vatish4, Anne Cathrine Staff5, Maria Sennström6, Matts Olovsson7, Shaun P. Brennecke8, Holger Stepan9, Deirdre Allegranza10, Carina Dinkel11, Maria Schoedl11, Martin Hund10, Stefan Verlohren12 1Department of Obstetrics and Gynecology, Medical University Vienna, Vienna, Austria
2Department of Obstetrics, Maternal-Fetal Medicine Unit, Hospital Universitari Vall d´Hebron, Barcelona, AND Maternal and Child Health and Development Network (SAMID) RD12/0026, Instituto de Salud Carlos III, Spain
3Department of Obstetrics and Gynecology, University of Liege, CHR de la Citadelle, Liege, Belgium
4Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, UK (previously University Hospitals NHS Trust, Coventry, UK)
5Department of Gynecology and Department of Obstetrics, Oslo University Hospital and University of Oslo, Oslo, Norway
6Department of Women’s and Children’s Health, Karolinska University Hospital, AND Karolinska Institute, Stockholm, Sweden
7Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
8Pregnancy Research Centre, Department of Perinatal Medicine, Royal Women’s Hospital and Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia
9Department of Obstetrics, University of Leipzig, Leipzig
10Roche Diagnostics International Ltd, Rotkreuz, Switzerland
11Roche Diagnostics GmbH, Penzberg, Germany
12Department of Obstetrics, Campus Virchow-Klinikum Charité, Berlin, Germany
O23 STEPS (Study of Early Preeclampsia in Spain): sFlt-1/PlGF for the prediction of early-onset preeclampsia in singleton pregnancies Alfredo Perales1, Juan Luis Delgado2, María de la Calle3, José A García-Hernández4, Ana Isabel Escudero5, José Manuel Campillos6, María Desamparados Sarabia2, Begoña Laíz1, Marta Duque3, Mercedes Navarro4, Pilar Calmarza6, Martin Hund7, Francisco V Álvarez5 1Hospital Universitario La Fe, Valencia, Spain
2Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
3Hospital Universitario La Paz, Madrid, Spain
4Hospital Universitario Materno-Infantil, Gran Canaria, Spain
5Hospital Universitario Central de Asturias, Oviedo, Spain
6Hospital Universitario Miguel Servet, Zaragoza, Spain
7Roche Diagnostics International Ltd, Rotkreuz, Switzerland
O24 Prediction of pre-eclampsia in obese nulliparous women Matias Vieira1, Dharmintra Pasupathy1, Robyn North1, Lesley McCowen2, Louise Kenny3, Lucilla Poston1 1King's College London, Division of Women's Health, London, UK
2University of Auckland, Department of Obstetrics and Gynecology, Auckland, New Zealand
3University College Cork, Department of Obstetrics and Gynecology, Cork, Ireland
O25 Evaluation of the value of the first and third trimester maternal mean platelet volume (MPV) for prediction of pre-eclampsia Maryam Kashanian Iran University of Medical Sciences, 3rd Department of Obstetrics, Tehran, Iran O27 Predicting Preeclampsia in a second pregnancy Doris Campbell, Sohinee Bhattacharya University of Aberdeen, Department of Obstetrics & Gynecology, Aberdeen, UK
15.45-16.15 Coffee break
16.15-17.30
Oral communication - Prevention Plenary Room
O28 Effect of folic acid supplementation in pregnancy on preeclampsia – Folic Acid Clinical Trial (FACT) Shi Wu Wen, Ruth Rennicks-White, Josee Champagne, Natalie Rybak, Laura Gaudet, Mark Walker The Ottawa Hospital, Department of Obstetrics, Gynecology and Newborn Care, Ottawa, Canada O29 The impact of low dose aspirin after positive first trimester screening for pre-eclampsia Ioana-Claudia Lakovschek1, Bence Csapo1, Vassiliki Kolovetsiou-Kreiner1, Christina Stern1, Karoline Mayer-Pickel1, Uwe Lang1, Barbara Obermayer-Pietsch2, Mila Cervar-Zivkovic1 1Medical University of Graz, Department of Obstetrics & Gynecology, Graz, Austria
2Medical University of Graz, Department of Internal Medicine, Graz, Austria
O30 Diet and Preeclampsia: A prospective multicentre unmatched Case Control Study in Ethiopia Mulualem Endeshaw Rift Valley University, 3rd Department of Obstetrics, Ethiopia (Bahir Dar), Ethiopia O31 Magnesium homeostasis and gestational hypertension Ragnar Rylander BioFAct Environmental Health Research Centre, Public Health, Lerum, Sweden O32 Pre-eclampsia and thrombophilia: prevention issues Ekaterina Zhuravleva, Viktoriya Bitsadze, Akexander Makatsariya First IM Sechenov Moscow State Medical University, Obstetrics and Gynecology, Moscow, Russia
17.30-18.30
Poster Plenary Room
P34 Role of high-mobility group A1 protein in trophoblast invasion Yuka Uchikura1, Keiichi Matsubara1, Yuko Matsubara1, Miki Mori2 1Ehime University, Department of Obstetrics and Gynecology, Toon, Japan
2Ehime Prefectural Central Hospital, Department of Obstetrics and Gynecology, Matsuyama, Japan
P35 Novel interaction of placental caveolin-1 expression with markers of oxidative stress and the renin-angiotensin system (RAS) in pre-eclampsia Hiten Mistry1, Anna Czajka2, Marta Hentschke3, Carlos Poli-de-Figueiredo3, Bartira Pinheiro da Costa3, Fiona Broughton Pipkin4, Lesia Kurlak4 1University of Bern, Department of Nephrology, Hypertension and Clinical Pharmacology, Berne, Switzerland 2King's College London, Diabetes Research Group, London, UK
3PUCRS, Laboratory of Nephrology , Porto Alegre, Brazil
4University of Nottingham, Department of Obstetrics & Gynecology, Nottingham, UK
P36 Identifying a novel link between preeclampsia and chronic hypertension in the MTHFR-gene using the population based Norwegian HUNT Study Liv Cecilie Thomsen1, Nina McCarthy2, Phillip Melton2, Gemma Cadby2, Rigmor Austgulen3, Eric Moses2, Line Bjørge4, Ann-Charlotte Iversen3 1Norwegian University of science and Technology (NTNU), Centre of Molecular Inflammation Research , Bergen, Norway
2University of Western Australia, Centre for Genetic Origins of Health and Disease, Perth, Australia
3Norwegian University of Science and Technology (NTNU), Centre of Molecular Inflammation Research, Trondheim, Norway
4Haukeland University Hospital, Department of Obstetrics & Gynecology, Bergen, Norway
P37 Alterations in maternal and fetal plasma soluable endothelial leukocyte adhesion molecule-1 (sE-selectin) concentrations in women with pre-eclampsia Lesia Kurlak1, Heidi Jamin2, Markus Mohaupt2, Hiten Mistry2 1University of Nottingham, Obstetrics and Gynecology, Nottingham, UK
2University of Bern, Department of Nephrology, Hypertension and Clinical Pharmacology, Berne, Switzerland
P38 Strong inhibitory effect of preeclampsia serum on angiogenesis using in vitro angiogenesis test Uotila Uotila1, Anita Virtanen1, Tarja Toimela2, Riina Sarkanen2, Outi Huttala2, Tuula Heinonen2 1Tampere University Hospital, Department of Obstetrics and Gynecology, Tampere, Finland
2FICAM, School of Medicine, Tampere, FICAM, Tampere, Finland
P39 Connection between placenta specific miRNA clusters and preeclampsia: a hypothetical miRNA-mRNA interaction network Orsolya Biró, Bálint Nagy, János Rigó Jr. Semmelweis University, 1st Department of Obstetrics and Gynecology, Budapest, Hungary P40 MIR-21 A and MIR-221 overexpression in placental tissue of preeclamptic patients Iveta Svecova1, Martin Vazan2, Pavol Zubor1, Jan Danko1, Zora Lasabova2 1Jessenius Medical Faculty, Comenius University, Martin, Slovakia, Department of Obstetrics & Gynecology, Martin, Slovakia
2Jessenius Medical Faculty, Comenius University, Martin, Slovakia, Institut of Molecular Biology, Martin, Slovakia
P41 The role of IL-10 polymorphism in pathology of hypertensive disorders in pregnancy Pavol Zubor1, Zora Lasabova2, Eva Jezkova1, Andrea Mendelova1, Iveta Svecova1, Jan Danko1 1Jessenius Medical Faculty, Comenius University, Martin, Slovakia, Department of Obstetrics & Gynecology, Martin, Slovakia
2Jessenius Medical Faculty, Comenius University, Martin, Slovakia, Institut of Molecular Biology, Martin, Slovakia
P42 TNF-ALPHA gene polymorphism in pathology of preeclampsia Pavol Zubor1, Andrea Mendelova2, Imrich Zigo1, Maria Skerenova3, Eva Jezkova2, Jan Danko1 1Jessenius Medical Faculty, Comenius University, Martin, Slovakia, Department of Obstetrics & Gynecology, Martin, Slovakia
2Jessenius Medical Faculty, Comenius University, Martin, Slovakia, Institut of Molecular Biology, Martin, Slovakia
3Jessenius Medical Faculty, Comenius University, Martin, Slovakia, Department of Medical Biochemistry, Martin, Slovakia
P43 Characterization of monocyte phenotype and polarization in preeclampsia and intrauterine fetal growth restriction Thushari Alahakoon1, Heather Medbury2, Helen Williams2, Nicole Fewings2, Xin Wang2, Vincent Lee3 1Westmead Hospital, Australia, Department of Obstetrics and Gynecology, Sydney, Australia
2University of Sydney, Sydney Medical School, Sydney, Australia
3Westmead Hospital, Australia, Department of Renal Medicine, Sydney, Australia
P44 Syncytiotrophoblast extracellular membrane vesicles from preeclamptic placentae show reduced abilities to guide monocyte maturation and activation as well as reduced activation of cytotoxicity of regulatory T-cells and NK-cells Claudia Göhner1, Jolien Fledderus2, Justine Fitzgerald3, Ekkehard Schleußner3, Udo Markert3, Torsten Plösch1, Sicco Scherjon1, Marijke Faas2 1University Medical Center Groningen, Department of Obstetrics and Gynecology, Groningen, The Netherlands
2University Medical Center Groningen, Department of Pathology and Medical Biology, Division of Medical Biology, Immunoendocrinology, Groningen, The Netherlands
3University Hospital Jena, Department of Obstetrics, Placenta-Lab, Jena, Germany
P45 Target cells of pregnancy-associated extracellular vesicles Árpád Ferenc Kovács1, Nóra Fekete1, Bálint Alasztics2, Gábor Joó2, Mária Prosszer2, Edit Buzás1, János Rigó Jr.2, Éva Pállinger1 1Semmelweis University, Department of Genetics, Cell- and Immunobiology, Budapest, Hungary
2Semmelweis University, 1st Department of Obstetrics and Gynaecology, Budapest, Hungary
P46 Dysregulated level of novel circulating autoantibodies in preeclampsia Kjartan Moe1, Harald Heidecke2, Ralf Dechend3, Anne Cathrine Staff1 1University of Oslo, Institute for Clinical Medicine, Oslo, Norway
2Celltrend GmbH, Luckenwalde, Germany
3The Charitè, Franz-Vollhard Clinic, HELIOS Clinic, Berlin, Germany
P47 First trimester urine and serum metabolomics to predict preeclampsia and gestational hypertension Marie Austdal1, Line Tangerås2, Ragnhild Skråstad3, Kjell Salvesen4, Rigmor Austgulen5, Tone Bathen6, Ann-Charlotte Iversen7 1Norwegian University of Science and Technology and St. Olavs Hospital, Department of Circulation and Medical Imaging, Trondheim, Norway
2Norwegian University of Science and Technology and St. Olavs Hospital, Centre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Trondheim, Norway
3Norwegian University of Science and Technology and St. Olavs Hospital, Department of Laboratory Medicine, Children's and Women's Health, Trondheim, Norway
4St. Olavs Hospital, National Centre for Fetal Medicine, Trondheim, Norway
5Norwegian University of science and Technology (NTNU), Centre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Trondheim, Norway
6Norwegian University of Science and Technology, Department of Circulation and Medical Imaging, Trondheim, Norway
7Norwegian University of Science and Technology, Centre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Trondheim, Norway
P48 Possible laboratory markers and anthropometric women with preeclampsia - preliminary results Natine Fuzihara Rosa, Stephany Risnic Chvaicer, Ana Paula de Almeida Righi, Claudia Valéria Chagas Siqueira, Diego Gomes Ferreira, Maria Renata Lopes Natale Poltronieri, Rogerio Gomes dos Reis Guidoni, Sergio Floriano Toledo, Leda Ferraz, Patricia Lopes Andrade, Francisco Lazaro Pereira Sousa, Vivian Macedo Gomes Marçal
UNILUS - Lusiada Foundation, 1st Department of Obstetrics and Gynaecology, Santos, Brazil P50 Microalbuminuria is a predictor of adverse pregnancy outcomes including preeclampsia Mathini Jayaballa1, Shreya Sood2, Thushari Alahakoon3, Suja Padmanabhan4, Wah Cheung4, Vincent Lee1 1Westmead Hospital, Australia, Department of Renal Medicine, Sydney, Australia
2University of Sydney, Sydney Medical School, Sydney, Australia
3Westmead Hospital, Australia, Department of Obstetrics & Gynecology, Sydney, Australia
4Westmead Hospital, Australia, Department of Endocrinology, Sydney, Australia
P51 Screening for preeclampsia in the first trimester: a reduced fat mass increases the risk in normo BMI patients Grazia Maria Tiralongo1, Ilaria Pisani1, Giulia Gagliardi1, Damiano Lo Presti1, Roberta Licia Scala2, Barbara Vasapollo3, Gianpaolo Novelli4, Angela Andreoli5, Herbert Valensise1 1University of Tor Vergata, Department of Obstetrics and Gynecology, Rome, Italy
2San Giovanni Calibita Fatebenefratelli Hospital, Department of Obstetrics and Gynecology, Rome, Italy
3San Giovanni Calibita Fatebenefratelli Hospital, Fatebenefratelli Association for Research, Rome, Italy
4San Sebastiano Martire Hospital, Department of Cardiology, Frascati (Rome), Italy
5University of Tor Vergata, Department of Physiology, Rome, Italy
P52 Prevalence of preeclampsia in patients of pre-gestational diabetic pregnancy in Bangladesh Mobashera Jahan1, Md Hasanuzzaman1, Sharmin Mahbuba1, K. Leena2, Gias U. Ahsan1, Thomas J. Kuehl3, M. Uddin3 1North South University, Department of Public Health, Dhaka, Bangladesh
2Brac University, James P. Grant School of Public Health, Dhaka, Bangladesh
3Baylor College of Medicine, Houston, Texas, USA, Obstetrics and Gynecology, Houston, USA
P53 Body mass index before pregnancy and hypertensive disorders in following pregnancy Ana Jakovljevic1, Mirjana Bogavac2, Aleksandra Nikolic3, Mirjana Milosevic-Tosic3, Zagorka Lozanov-Crvenkovic4 1University of Novi Sad Medical Faculty, Clinical Centre of Vojvodina , Centre for Laboratory Medicine, Novi Sad, Serbia
2University of Novi Sad Medical Faculty, Clinical Centre of Vojvodina, Department of Obstetrics and Gynecology, Novi Sad, Serbia
3University of Novi Sad Medical Faculty, Clinical Centre of Vojvodina, Emergency Center, Urgent Laboratory at Department of Obstetrics and Gynecology, Novi Sad, Serbia
4University of Novi Sad Faculty, Faculty of Science Department of Mathematics and Informatics, Novi Sad, Serbia
18.30- Welcome reception

Friday, 25 SEPTEMBER

08.00-09.40
State of the Art Lecture, Plenary Lecture Plenary Room
STA54 Preeclampsia – Myths are still stronger than scientific data Berthold Huppertz Medical University of Graz, Institute of Cell Biology, Histology & Embryology, Graz, Austria STA55 Pathophysiology of preeclampsia from the view point of immunology Shigeru Saito1, Arihiro Shiozaki1, Akitoshi Nakashima1, Yasushi Nakabayashi1, Attila Molvarec2, János Rigó Jr.2 1University of Toyama, Obstetrics and Gynecology, Toyama, Japan
2Semmelweis University, 1st Department of Obstetrics and Gynecology, Budapest, Hungary
PL56 Lon-term consequences of preeclampsia Annetine Staff University of Oslo,Oslo, Norway PL138 Should we be using predictive tests for Pre-eclampsia in routine clinical practice? Louise Kenny University of Oslo, Norway
09.40-10.00 Coffee break
10.00-11.00
Plenary Lecture Plenary Room
PL57 Angiogenic factors: from scientific data to clinical implementation Holger Stepan Leipzig University, Department of Obstetrics, Leipzig, Germany PL58 Low molecular weight heparin for prevention of severe preeclampsia and other placental mediated complications Michael Kupferminc Tel Aviv Medical Center, Tel Aviv University, Obstetrics and Gynecology, Tel Aviv, Israel PL59 The impact of classification of hypertensive disorders of pregnancy based on the ACOG 2013 and ISSHP 2014 criteria János Rigó Jr., Bálint Alasztics, Anikó Árokszállási, Noémi Dobó, Mária Prosszer, János Gábor Joó, Attila Molvarec Semmelweis University, 1st Department of Obstetrics and Gynecology, Budapest, Hungary A new Database for all Preeclampsia Researchers. From the Global Pregnancy Collaboration Chritopher Redman University of Oxford, Nuffield Department of Obstetrics and Gynecology, Oxford, UK
11.00-12.30
Oral communication - Management of preeclampsia I. Plenary Room
O60 Treatment of hypertension in pregnancy Csaba Farsang St. Imre University Teaching Hospital, Budapest, Hungary O61 The Treatment of Antenatal Hypertension With Labetalol: A Prediction Model for Successful Response Daniel Stott, Mareike Bolten , Dana Paraschiv, Mona Salman , Katherine Clark, Nikos Kametas King's College London, Department of Women’s and Children’s Health, London, UK O62 Use of diuretics in the management of late-onset preeclampsia Péter Tamás1,2, Eszter Hantosi1,2, Bálint Farkas2, József Bódis1,2 1Department of Obstetrics and Gynecology, Faculty of Medicine, University of Pécs
2Doctorial School of Health Sciences, Faculty of Health Sciences, University of Pécs, Hungary
O63 Removal of Soluble Fms-like Tyrosine Kinase (sFlt-1) by Plasma-Specific Apheresis: Pilot Study in Women with Very Preterm Preeclampsia Wiebke Schaarschmidt Leipzig University, Obstetrics and Gynecology, Leipzig, Germany O64 Timing of delivery in Preeclampsia Helena Strevens Lund University, Department of Obstetrics and Gynecology, Lund, Sweden O65 Is there evidence to inform antihypertensive prescribing in pregnancy complicated by chronic hypertension: a systematic review Louise Webster, Frances Conti-Ramsden, Paul Seed, Catherine Nelson-Piercy, Lucy Chappell King's College London, Women's Health Academic Centre, London, UK
Oral communication - Management of preeclampsia II. Section Room
O66 Comparison of immediate delivery versus expectant management in women with severe early onset preeclampsia before 26 weeks of gestation Miriam F. Van Oostwaard1, Leonoor Van Eerden2, Monique W. De Laat3, Hans J. Duvekot4, Jan Jaap H.M. Erwich5, Kitty W.M. Bloemenkamp6, Antoinette Bolte7, Joost P.F. Bosma8, Steven V. Koenen9, René F. Kornelisse10, Bente Rethans3, Pieter Van Runnard Heimel11, Hubertina C.J. Scheepers12, Wessel Ganzevoort3, Ben Willem J. Mol13, Christianne J. De Groot14, Ingrid P.M. Gaugler-Senden15 1Department of Obstetrics and Gynaecology, Beatrixziekenhuis, Gorinchem, The Netherlands
2Department of Obstetrics and Gynaecology, Maasstad Ziekenhuis, Rotterdam, The Netherlands
3Department of Obstetrics and Gynaecology, Academisch Medisch Centrum, Amsterdam, The Netherlands
4Department of Obstetrics and Gynaecology, Erasmus Medisch Centrum, Rotterdam, The Netherlands
5Department of Obstetrics and Gynaecology, Universitair Medisch Centrum Groningen, The Netherlands
6Department of Obstetrics and Gynaecology, Leids Universitair Medisch Centrum, Leiden, The Netherlands
7Department of Obstetrics and Gynaecology, Radboud Universitair Medisch Centrum, The Netherlands
8Department of Obstetrics and Gynaecology, Isala Ziekenhuis, Zwolle
9Department of Obstetrics and Gynaecology, Universitair Medisch Centrum Utrecht, The Netherlands
10Department of Paediatrics, Erasmus Medisch Centrum, Rotterdam, the Netherlands
11Department of Obstetrics and Gynaecology, Maxima Medisch Centrum, Veldhoven, The Netherlands
12Department of Obstetrics and Gynaecology, Maastricht Universitair Medisch Centrum, The Netherlands
13School of Paediatrics and Reproductive Health, University of Adelaide, 5000 SA Australia
14Department of Obstetrics and Gynaecology, VU Universitair Medisch Centrum, Amsterdam, The Netherlands
15Department of Obstetrics and Gynaecology, Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch, The Netherlands
O67 The cranial imaging in severe preeclampsia XiaoDan Di1, Hui Mai2, JinYing Yang1, HuiShu Liu1 1Guangzhou Women and Children’s Medical Center, Department of Obstetrics, GuangZhou, China 2The third affiliated hospital of Guangzhou Medical University, Department of Radiology, GuangZhou, China O68 Management of eclampsia and stroke during pregnancy Yasumasa Ono OHNO Ladies Clinic, Obstetrics and Gynecology, Iwakura, Japan O69 Visual Evoked Potential as neurophysiological evaluation of patients with severe PE and visual disturbances Ingrid Brussé Erasmus MC, Department of Obstetrics & Gynecology, Rotterdam, The Netherlands O70 What is the optimal management for screening, diagnosis and management of preeclampsia today? Mila Cervar-Zivkovics Medical University of Graz, Department of Gynecology and Obstetrics, Graz, Austria
12.30-13.30 Break
13.30-15.30
Oral communication - Immunology Plenary Room
O72 Monocyte-macrophage system in pregnancy complications from the prospective of extracellular vesicles Éva Pállinger1, Nóra Fekete1, Anikó Árokszállási2, Gábor Joó2, Edit Buzás1, János Rigó Jr.2 1Semmelweis University, Department of Genetics, Cell- and Immunobiology, Budapest, Hungary
2Semmelweis University, 1st Department of Obstetrics and Gynaecology, Budapest, Hungary
O73 The role of Th17/Treg imbalance in normal pregnancy and pre-eclampsia Dorota Darmochwal-Kolarz1, Bogdan Kolarz2, Magdalena Kludka-Sternik3, Jan Oleszczuk1 1Medical University of Lublin, Department of Obstetrics and Perinatology, Lublin, Poland
2University of Rzeszow, Centre for Innovative Research in Medical and Natural Sciences, Rzeszow, Poland
3Medical University of Lublin, 3rd Department of Gynecology, Lublin, Poland
O74 Granulocyte and monocyte phagocytosis index affected by plasma factors in normal and preeclamptic pregnancy Rudolf Lampé, Ágnes Kövér, Robert Póka University of Debrecen, Department of Obstetrics and Gynecology, Debrecen, Hungary O75 B7 Costimulation and Intracellular Indoleamine-2,3-Dioxygenase Expression in Peripheral Blood of Healthy Pregnant and Preeclamptic Women Gergely Toldi, Attila Molvarec, László Berta, Anna Bajnok, János Rigó Jr Semmelweis University, 1st Department of Obstetrics and Gynecology, Budapest, Hungary O76 The role of costimulatory molecules in the pathogenesis of pre-eclampsia Dorota Darmochwal-Kolarz1, Bogdan Kolarz2, Tomasz Chmielewski3, Jan Oleszczuk1 1Medical University of Lublin, Department of Obstetrics and Perinatology, Lublin, Poland
2University of Rzeszow, Centre for Innovative Research in Medical and Natural Sciences, Rzeszow, Poland
3Medical University of Lublin, Depertment of Clinical Immunology, Lublin, Poland
O77 Functional screening of Toll-like receptors in seven trophoblast cell lines Lobke Gierman1, Guro Stødle1, Line Tangerås1, Marie Austdal2, Guro Olsen1, Turid Follestad3, Bente Skei1, Kristin Rian4, Astrid Gundersen1, Rigmor Austgulen1, Ann-Charlotte Iversen1 1Norwegian University of Science and Technology, Centre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Trondheim, Norway
2Norwegian University of Science and Technology, Department of Circulation and Medical Imaging, Trondheim, Norway
3Norwegian University of Science and Technology, Department of Mathematical Sciences, Trondheim, Norway
4Norwegian University of Science and Technology, Department of Laboratory Medicine, Children's and Women's Health, Trondheim, Norway
O78 The inflammatory role of HMGB1 in preeclampsia Line Tangerås1, Guro Stødle1, Gabriela Silva1, Liv Cecilie Thomsen2, Lobke Gierman1, Bente Skei1, Karin Collett3, Merete Myklebost4, Anne Lise Beversmark4, Ragnhild Skråstad5, Rigmor Austgulen1, Line Bjørge2, Ann-Charlotte Iversen1 1Norwegian University of Science and Technology, Centre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Trondheim, Norway
2Haukeland University Hospital, University of Bergen, Department of Obstetrics and Gynecology, Bergen, Norway
3Haukeland University Hospital, Department of Pathology, Bergen, Norway
4St. Olavs Hospital, Department of Obstetrics and Gynecology, Trondheim, Norway
5Norwegian University of Science and Technology and St. Olavs Hospital, Department of Obstetrics and Gynecology and Department of Laboratory Medicine Children's and Women's Health, Trondheim, Norway
O137 Developing, disseminating, and implementing a core outcome set for pre-eclampsia James M. N. Duffy On behalf of iHOPE: International Collaboration to Harmonise Outcomes for Pre-eclampsia, University of Oxford, Oxford, United Kingdom
Oral communication - Angiogenesis Section Room
O79 An intermediate sFlt-1/PlGF ratio without preeclampsia indicates preterm delivery Victoria Ossada, Janine Hoffmann, Holger Stepan University of Leipzig, Department of Obstetrics, Leipzig, Germany O80 The SFLT-1/PlGF ratio associates with prolongation of pregnancy Langeza Saleh Erasmus MC, Department of Gynecology and Department of Obstetrics, Rotterdam, The Netherlands O81 The impact of uterine curettage post partum on maternal sFlt-1 concentration Victoria Ossada, Alexander Jank, Holger Stepan University of Leipzig, Department of Obstetrics, Leipzig, Germany O82 Association between anti-angiogenic factor and signs of arterial aging in women with preeclampsia Tansim Akhter1, Anna-Karin Wikström1, Marita Larsson1, Anders Larsson2, Tord Naessen1 1Uppsala University, Obstetrics and Gynecology, Uppsala, Sweden
2Uppsala University, Clinical Chemistry, Uppsala, Sweden
O83 Angiogenic factor imbalance contributes to the pathophysiology of preeclampsia among rural African women Allen Meeme Walter Sisulu University, Obstetrics and Gynecology, Mthatha, South Africa O84 Hydrogen sulphide rescues the preeclampsia phenotype aggravated by high sFlt-1 in placenta growth factor deficient pregnant mouse Shakil Ahmad, Keqing Wang, Asif Ahmed Aston University, Birmingham, Medical School, Birmingham, UK
15.30-16.00 Coffee break
16.00-17.00
Workshop Plenary Room
WH85 Biomarker Discovery in Preeclampsia: present and future challenges: Taking a biomarker into clinical practice Lucy Chappell King's College London, Women's Health Academic Centre, London, UK WH86 Using proteomics for the discovery of biomarkers: promise and pitfalls Jenny Myers University of Manchester, Maternal & Fetal Health Research Centre, Manchester, UK
17.00-18.00
Poster Plenary Room
P33 Decreasing of placental progesterone induced blocking factor expression and spiral artery remodeling disturbance in mice preeclampsia model Manggala Pasca Wardhana1, Budi Wicaksono1, Erry Gumilar Dachlan1, Muhammad Ilham Aldika Akbar1, Ernawati Ernawati1, Agus Sulistyono1, Aditiawarman Aditiawarman1, Hermanto Tri Juwono1, Widjiati Widjiati2 1Airlangga University, Department of Obstetrics and Gynecology, Surabaya, Indonesia
2Airlangga University, Medical Veterinary Faculty, Surabaya, Indonesia
P87 Alteration of Delta-like ligand 1 and Notch 1 receptor in various placental disorders with special reference to early-onset preeclampsia Yota Shimanuki1, Hiroyuki Mitomi2, Yuki Fukumura3, Shintaro Makino1, Atsuo Itakura1, Takashi Yao3, Satoru Takeda1 1Juntendo University Faculty of Medicine, Department of Obstetrics and Gynecology, Tokyo, Japan
2Dokkyo Medical University School of Medicine, Department of Surgical and Molecular Pathology, Tochigi, Japan
3Juntendo University Faculty of Medicine, Department of Human Pathology, Tokyo, Japan
P88 Pre-eclampsia risk stratification for low risk 1st pregnancies: First results of a new LC-MS based multiplex metabolite assay Liz Bond1, Grégoire Thomas2, Caroline Nolan1, Louise Kenny3, Philip Baker4, Robin Tuytten1 1Metabolomic Diagnostics, Research and Development, Little Island, Ireland
2Squ4Re, Lokeren, Belgium
3Cork University Maternity Hospital, The Irish Centre for Fetal and Neonatal Translational Research, Cork, Ireland
4University of Auckland, Gravida: National Centre for Growth and Development, Auckland, New Zealand
P89 Biochemical parameters of the first trimester in preeclampsia Mirjana Bogavac1, Ana Jakovljevic2, Aleksandra Nikolic3, Mirjana Milosevic-Tosic3, Zagorka Lozanov-Crvenkovic4, Zoran Novakovic5 1University of Novi Sad Medical Faculty, Clinical Centre Vojvodina Department of Obstetrics and Gynecology , Novi Sad, Serbia
2University of Novi Sad Medical Faculty, Clinical Centre of Vojvodina, Centre for Laboratory Medicine, Novi Sad, Serbia
3University of Novi Sad Medical Faculty, Clinical Centre of Vojvodina, Emergency Center, Urgent Laboratory at Department of Obstetrics and Gynecology, Novi Sad, Serbia
4University of Novi Sad,Faculty of Science, Department of Mathematics and Informatics, Novi Sad, Serbia
5University of Novi Sad, Medical Faculty, Novi Sad, Serbia
P90 Effect of angiotensin II receptor subtype2 stimulant on the pathogenesis of preeclampsia Keiichi Matsubara, Miki Mori, Yuka Uchikura, Yuko Matsubara Ehime University, Obstetrics and Gynecology, Toon, Japan P91 Possible Therapeutics for Preeclampsia: Drug Repositioning by In Vitro Screening via Induction of Placental Growth Factor Kazuya Mimura Osaka University Graduate School of Medicine, Department of Obstetrics and Gynecology, Suita, Japan P92 When there is a lack of magnesium during pregnancy Anna Vachulova1, Monika Kaldararova2, Andrea Vaskova3, Peter Tittel2 1National Cardiovascular Insitute, Department of Arrhythmias and Permanent Pacing, Bratislava, Slovakia
2National Cardiovascular Insitute, Department of Functional Diagnostics, Bratislava, Slovakia
3J. A. Reiman University Hospital, Department of Gynecology and Obstetrics, Presov, Slovakia
P93 Early-onset eclampsia with intrauterine fetal death after placental abruption at 22 weeks gestation: a case report and literature review Aiko Shigemitsu Nara Medical University, Department of Obstetrics & Gynecology, Kashihara, Japan P94 Preeclampsia in pregnancies with and without diabetes; the associations with placental weight. A population study of 655 842 pregnancies Johanne Dypvik1, Ellen Marie Strøm-Roum1, Camilla Haavaldsen1, Lars Johan Vatten2, Anne Eskild1 1Akershus University Hospital, Department of Obstetrics & Gynecology, Lørenskog, Norway
2Norwegian University of Science and Technology (NTNU), Department of Public Health, Trondheim, Norway
P95 Perinatal outcome of pregnant with severe preeclampsia and gestational diabetes mellitus in rondônia - brazil: case report Gizeli Gimenez1, Ticiana Albuquerque Gonçalves1, Maiky Jose de Oliveira2, Rita Ferreira Silva1 1Fundação Universidade Federal De Rondônia, Departamento De Medicina, Porto Velho, Brazil
2FACIMED, Cacoal, Porto Velho, Brazil
P96 Neonatal outcome in women after kidney transplantation: effect of immunosuppressive therapy on the risk of preeclampsia Hester Zweers1, Henk Van Hamersvelt2, Renate Van der Molen3, Olivier Van der Heijden1 1Radboud University Medical Centre Nijmegen, Department of Obstetrics and Perinatology, Nijmegen, The Netherlands
2Radboud University Medical Centre Nijmegen, Department of Renal Medicine, Nijmegen, The Netherlands
3Radboud University Medical Centre Nijmegen, Department of Medical Immunology, Nijmegen, The Netherlands
P97 Chronic Kidney Disease and Pregnancy – A case report Sara Nascimento, Mariana Miranda, Teresa Matos, Fernanda Matos, Antónia Nazaré Hospital Prof. Doutor Fernando Fonseca, EPE, Department of Obstetrics and Gynecology, Amadora, Portugal P98 M Maternal lipid- and steroid hormone concentrations during the course of pregnancy and in pregnancy pathologies Ulrich Pecks1, Nicola Kleine-Eggebrecht 2, Nicolai Maass1, Geneviève Escher3, Werner Rath2, Markus Mohaupt3 1University Hospital of Schleswig-Holstein Campus Kiel, 1st Department of Obstetrics and Gynaecology, Kiel, Germany
2University Hospital of the RWTH, 1st Department of Obstetrics and Gynaecology, Aachen, Germany
3University of Bern, Department of Nephrology, Hypertension and Clinical Pharmacology, Berne, Switzerland
P99 Use of High Dose Cortisosteroids in HELLP Syndrome Ioana-Claudia Lakovschek, Christiane Barthel, Bence Csapo, Vassiliki Kolovetsiou-Kreiner, Christina Stern, Karoline Mayer-Pickel, Uwe Lang, Mila Cervar-Zivkovic Medical University of Graz, Department of Obstetrics & Gynecology, Graz, Austria P100 Differences in depression scores between women with a history of term hypertensive pregnancy disorders and women with a history of uncomplicated pregnancies. Wietske Hermes1, Floortje Van Kesteren2, Marielle Van Pampus3, Kitty Bloemenkamp4, Arie Franx5, Ben Mol6, Christianne De Groot7 1Medical Center Haaglanden, Department of Obstetrics and Gynecology, The Hague, The Netherlands
2Academisch Medisch Centrum, Amsterdam, Department of Radiology, Amsterdam, The Netherlands
3Onze Lieve Vrouwe Gasthuis, Department of Obstetrics and Gynecology, Amsterdam, The Netherlands
4Leiden University Medical Center, Department of Obstetrics, Leiden, The Netherlands
5University Medical Center Utrecht, Department of Obstetrics and Gynecology, Utrecht, The Netherlands
6University of Adelaide, Department of Obstetrics and Gynecology, Adelaide, Australia
7VU Medical Center Amsterdam, Department of Obstetrics and Gynecology, Amsterdam, The Netherlands
P101 Cardiac function and ventriculo-arterial interaction11 years after preeclampsia complicated pregnancy Maha Al-Nashi Karolinska University Hospital, Dept. Obstetrics, Stockholm, Sweden P102 Placental weight in the first pregnancy and risk for preeclampsia in second pregnancy: a population cohort study of 186 859 women Sandra Larsen1, Johanne Dypvik1, Camillla Haavaldsen1, Lars Vatten2, Anne Eskild1 1Akershus University Hospital, Department of Obstetrics and Gynecology, Lørenskog, Norway
2Norwegian University of Science and Technology (NTNU), Department of Public Health, Trondheim, Norway
P103 Relationship between severe preeclampsia onset with iugr incidence at dr. Soetomo General Hospital in 2013 Budi Wicaksono1, Ryan Intan2, Budi Utomo3 1Soetomo General Hospital Surabaya Indonesia, Obstetric and Ginecology, Surabaya, Indonesia
2Airlangga University, Medical School, Surabaya, Indonesia
3Airlangga University, Public Health, Surabaya, Indonesia
P104 Stromal derived factor-1α is a key to improving neonatal brain injuries Miki Mori1, Keiichi Matsubara2, Yuko Matsubara2, Yuka Uchikura2, Hiroshi Ochi1 1Ehime Prefectural Central Hospital, Obstetrics and Gynecology, Matsuyama, Japan
2Ehime University, Obstetrics and Gynecology, Toon, Japan
19.30- Gala dinner

Saturday, 26 SEPTEMBER

08.00-10.00
State of the Art Lecture, Plenary Lecture Plenary Room
STA105 PlGF: more than a pre-eclampsia biomarker. Results from the CoLAB Angiogenic Factor Study of 16 000 pregnancies Anne Cathrine Staff University of Oslo, Obstetrics and Gynecology, Oslo, Norway STA106 Maternal cardiac function before and during preeclampsia: we must study the heart in pregnacy Herbert Valensise University of Tor Vergata, Biomedical Imaging, Rome, Italy PL107 Monocytes in pregnancy and preeclampsia Marijke Faas University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands PL108 Inflammatory mechanisms in preeclampsia Attila Molvarec, János Rigó Jr. Semmelweis University, 1st Department of Obstetrics and Gynecology, Budapest, Hungary PL109 Corticosteroids in the management of severe preeclampsia: what evidence? Alex Vidaeff Baylor College of Medicine, Obstetrics and Gynecology, Houston, USA
10.00-10.30 Break
10.30-12.15
Oral communication - Cardiovascular changes in preeclampsia Plenary Room
O110 Maternal Left Ventricular dysfunction and Remodeling in Pregnancy Complicated with Gestational Hypertension Orsolya Szenczi, János Rigó Jr. Semmelweis University, 1st Department of Obstetrics and Gynecology, Budapest, Hungary O111 The association between maternal haemodynamics and pre-eclampsia: systematic review and meta-analysis Silvia Selvi1, Basky Thilaganathan2, Francesco D'Antonio2, Lamberto Manzoli3, Asma Khalil2 1St George's Hospital, University of London, Fetal Maternal Medicine Unit, London, UK
2St George's Hospital, University of London, Maternal-Fetal Department, London, UK
3University of Chieti-Pescara, Obstetrics and Gynecology, Rome, Italy
O112 Inotropy index and ratio of potential to kinetic energy: Two novel parameters derived from continuous-wave Doppler ultrasound Sophie Bowe, Basky Thilaganathan, Elena Mantovani, Asma Khalil St George's Hospital, University of London, Maternal-Fetal Department, London, UK O113 Measurements of arterial stiffness and uterine artery Doppler for the prediction of preeclampsia in women presenting with gestational hypertension Asma Khalil, Sophie Bowe, Basky Thilaganathan, Dimuthu Vinayagam, Elena Mantovani St George's Hospital, University of London, Maternal-Fetal Department, London, UK O114 Maternal cardiovascular changes in pregnancies complicated by small for gestational age neonate with or without maternal hypertension Sophie Bowe, Basky Thilaganathan, Dimuthu Vinayagam, Asma Khalil St George's Hospital, University of London, Maternal-Fetal Department, London, UK O115 First trimester maternal vascular function is associated with fetal growth Charlotte Iacobaeus1, Thomas Kahan1, Ellika Andolf1, Malin Thorsell1, Gun Jörneskog1, Katarna Bremme2 1Karolinska Institute, Department of Clinical Science, Danderyd Hospital, Stockholm, Sweden
2Karolinska Institute, Department of Women’s and Children’s Health, Stockholm, Sweden
O116 Can maternal haemodynamics predict hypertensive disorders in pregnancy? Asma Khalil St George's Hospital, University of London, Maternal-Fetal Department, London, UK
Oral communication - Long term complications of preeclampsia Section Room
O117 Role of some biomarkers in long term cardiovascular prognosis of pregnancy hypertensive disease Manuel Bicho1, Andreia Matos1, Alda Pereira da Silva1, Maria Clara Bicho1, Maria José Areias2, Irene Rebelo3 1University of Lisbon, Faculty of Medicine, Genetics Laboratory and Environmental Health Institute, Lisbon, Portugal
2Maria Pia Hospital, Júlio Diniz Maternity, Porto, Portugal
3Faculty of Pharmacy/ Institute for Molecular and Cell Biology, University of Porto, Laboratory of Biochemistry, Porto, Portugal
O118 Subsequent preeclampsia is associated with worse subclinical left ventricular dysfunction York Yann Chow1, Deven Mahadavan2, Gus Dekker3, Noriko Warren2, Melanie Wittwer1, Vikki Clifton4, Margaret Arstall1 1Lyell McEwin Hospital, University of Adelaide, Department of Cardiology, Adelaide, Australia
2Lyell McEwin Hosptial , Department of Cardiology, Adelaide, Australia
3Lyell McEwin Hospital, University of Adelaide, Department of Gynecology and Department of Obstetrics, Adelaide, Australia
4Mater Medial Research Institute, Wollongabba, Australia
O119 Cardiovascular risk management after reproductive and pregnancy related disorders: a Dutch multidisciplinary evidence-based guideline Karst Heida1, Michiel Bots2, Miram Cohen3, Frederique Van Dunné4, Christianne De Groot5, Nurah Hammoud1, Annemiek Hoek6, Joop Laven7, Angela Maas8, Jeanine Roeters van Lennep9, Birgitta Velthuis10, Arie Franx1 1University Medical Center Utrecht, Department of Obstetrics, Utrecht, The Netherlands
2University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands
3Camper Practice, Primary Care, Amsterdam, The Netherlands
4Medical Center Haaglanden, Department of Obstetrics, The Hague, The Netherlands
5VU Medical Center Amsterdam, Department of Obstetrics, Amsterdam, The Netherlands
6University Medical Center Groningen, Department of Obstetrics & Gynecology, Groningen, The Netherlands
7Erasmus MC, Department of Obstetrics & Gynecology, Rotterdam, The Netherlands
8Radboud University Medical Center, Department of Cardiology, Nijmegen, The Netherlands
9Erasmus MC, Department of Internal Medicine, Rotterdam, The Netherlands
10University Medical Center Utrecht, Department of Radiology, Utrecht, The Netherlands
O120 Increased myeloperoxidase is a cardiovascular risk biomarker in women with previous preeclampsia Andreia Matos1, Alice Rivera2, Alda Pereira da Silva1, Ana Portelinha3, Maria José Areias4, Irene Rebelo5, Manuel Bicho1, José R. Romero6 1Faculty of Medicine of University of Lisbon and Instituto de Investigação Científica Bento da Rocha Cabral, Genetics Laboratory and Environmental Health Institute, Lisbon, Portugal
2Boston Children’s Hospital and Harvard Medical School, Depts. of Pathology and Laboratory Medicine, Boston, USA
3New University of Lisbon, Chronic Diseases Research Centre (CEDOC), Lisbon, Portugal
4Maria Pia Hospital, Júlio Diniz Maternity, Porto, Portugal
5Faculty of Pharmacy/ Institute for Molecular and Cell Biology, University of Porto, Laboratory of Biochemistry, Porto, Portugal
6Brigham and Women’s Hospital and Dept. of Medicine, Harvard Medical School, Div. of Endocrinology, Diabetes and Hypertension, Boston, USA
O121 Maternal metabolic outcomes in women with a history of hypertensive pregnancy disorders Laura Benschop1, Jeanine E. Roeters-van Lennep2, Sarah Schalekamp-Timmermans1, Vincent W.V. Jaddoe3, Nienke E. Bergen1, Eric A.P. Steegers1 1Erasmus MC, Department of Obstetrics & Gynecology, Rotterdam, The Netherlands
2Erasmus MC, Department of Internal Medicine, Rotterdam, The Netherlands
3Erasmus MC, Dept. Epideimology & Dept. Pediatrics, Rotterdam, The Netherlands
O122 The role of framing in modifying behavior to reduce cardiovascular risk after preeclampsia, a vignette study Anouk Bokslag1, Wietske Hermes2, Christianne De Groot1, Pim Teunissen3 1VU Medical Center Amsterdam, Department of Obstetrics & Gynecology, Amsterdam, The Netherlands
2Medical Center Haaglanden, Department of Obstetrics & Gynecology, The Hague, The Netherlands
3VU Medical Center Amsterdam, 1st Department of Obstetrics and Gynaecology, Amsterdam, The Netherlands
O123 Hypertensive disorders of pregnancy and subsequent risk of cancer – a population-based cohort study Ida Behrens1, Saima Basit2, Allan Jensen3, Jacob Lykke4, Lars Peter Nielsen5, Jan Wohlfahrt2, Susanne Krüger Kjaer3, Mads Melbye2, Heather Boyd2 1Statens Serum Institut, Dept. of Epidemiology Research, Copenhagen, Denmark
2Statens Serum Institut, Department of Epidemiology Research, Copenhagen, Denmark
3The Danish Cancer Society Research Center, Unit of Virus, Lifestyle and Genes, Copenhagen, Denmark
4Copenhagen University Hospital, Hvidovre, Department of Obstetrics and Gynecology, Copenhagen, Denmark
5Statens Serum Institut, Department of Autoimmunology and Biomarkers, Copenhagen, Denmark
12.15-12.45 Coffee break
12.45-14.15
Oral communication - Others I. Plenary Room
O124 Preeclampsia: Two different clinical phenotypes - two different pregnancy outcomes Zulfiya Khodzhaeva Moscow Federal Research Center for Ob-Gyn & Perinatology, Maternal-Fetal Department, Moscow, Russia O125 Ethnicity: an independent risk factor for adverse perinatal outcome in women with chronic hypertension Louise Webster1, Kate Bramham1, Paul Seed1, Michelle Homsy1, Catherine Nelson-Piercy1, Basky Thilaganathan2, Lucy Chappell1 1King's College London, Women's Health Academic Centre, London, UK
2St George's Hospital, University of London, Fetal Maternal Medicine Unit, London, UK
O126 Postnatal neurological development follow-up of newborns from pregnancies with hypertension associated intrauterine growth restriction (IUGR) József Gábor Joó, Boróka Ujvárosi, Anna Beke, János Rigó Jr. Semmelweis University, 1st Department of Obstetrics and Gynecology, Budapest, Hungary O127 Low levels of plasma protein S, protein C and coagulation factor XII during early pregnancy and adverse pregnancy outcome Yasuhiko Ebina1, Masahiro Ieko2, Sumiyoshi Naito3, Gen Kobashi4, Masashi Deguchi1, Hisanori Minakami5, Tatsuya Atsumi6, Hideto Yamada1 1Kobe University Graduate School of Medicine, Department of Obstetrics and Gynecology, Kobe, Japan
2Health Sciences University of Hokkaido, Department of Internal Medicine, Ishikari-Tobetsu, Japan
3Health Sciences University of Hokkaido, Department of Clinical Laboratory, Ishikari-Tobetsu, Japan
4Dokkyo Medical University School of Medicine, Department of Public Hearth, Mibu, Japan
5Hokkaido University Graduate School of Medicine, Department of Obstetrics and Gynecology, Sapporo, Japan
6Hokkaido University Graduate School of Medicine, Department of Medicine II, Sapporo, Japan
O128 Placental vascularization indices and uterine artery peak systolic velocity in pregnancy hypertension Ábel Tamás Altorjay1, Andrea Surányi1, Tibor Nyári2, Gábor Németh1 1University of Szeged, Department of Obstetrics and Gynecology, Szeged, Hungary 2University of Szeged, Department of Medical Physics and Informatics, Szeged, Hungary
Oral communication - Others II. Section Room
O130 Urinary congophilia in women with preeclampsia and chronic kidney disease Fergus McCarthy1, Adedamola Adetoba2, Carolyn Gill2, Kate Braham2, Maria Bertolaccini2, Guillermina Girardi2, Lucilla Poston2, Lucy Chappell2 1King's College London, Women's Health Academic Centre, London, UK
2King's College London, Division of Women's Health, London, UK
O131 Pravastatin protects against glucose-induced anti-proliferative, anti-invasive and anti-angiogenic milieu in cytotrophoblasts M. Nasir Uddin Texas A&M Health Care Centre, Department of Obstetrics & Gynecology, Temple, USA O132 Comparison of groups with and without diabetes mellitus and preeclampsia in pregnancy: a retrospective case-control comparison M. Nasir Uddin Texas A&M Health Care Centre, Department of Obstetrics & Gynecology, Temple, USA O133 Fetal renal vascularisation in pregnancy induced hypertension complicated by gestational diabetes or intrauterine growth restriction Andrea Surányi, Ábel Altorjay, Gábor Németh University of Szeged, Department of Obstetrics & Gynecology, Szeged, Hungary O134 Polycystic ovary syndrome as a risk factor of pregnancy induced hypertension - review of the literature Szabolcs Varbiro Semmelweis University, Department of Obstetrics & Gynecology, Budapest, Hungary O135 HELLP??? - a case Eva-Christine Weiss, Gordana Tomasch, Uwe Lang, Wolfgang Schöll Medical University of Graz, Department of Obstetrics & Gynecology, Graz, Austria
14.15-14.45 Closing Ceremony